Abstract
Hepatocellular carcinoma (HCC) represents 75% of cases of primary liver cancer, which is the seventh most common cancer globally. Hepatocarcinogenesis is a complex and multistep process involving the accumulation of genetic changes and resulting in altered expression of cancer-related genes, such as oncogenes and tumor suppressor genes, and their related molecular signaling pathways. To understand such complex processes, it is important to have good experimental models that accurately recapitulate the steps of hepatocarcinogenesis in humans. The chapter summarizes the available experimental models for studying HCC. Since genomic characteristics of HCC closely reflect biology and clinical outcomes, the chapter also describes how accurately experimental models recapitulate human HCC at the genome level. Genome-wide comparison of mouse models with human HCC would be the best way to identify the most appropriate mouse models for various subtypes of human HCC.
Original language | English (US) |
---|---|
Title of host publication | The Liver |
Subtitle of host publication | Biology and Pathobiology |
Publisher | wiley |
Pages | 749-757 |
Number of pages | 9 |
ISBN (Electronic) | 9781119436812 |
ISBN (Print) | 9781119436829 |
DOIs | |
State | Published - Jan 24 2020 |
Keywords
- Chemically induced models
- Genetically engineered mouse models
- Genomic assessment
- Hepatocarcinogenesis
- Hepatocellular carcinoma
- Liver cancer
- Molecular signaling pathways
- Non-mouse models
ASJC Scopus subject areas
- General Medicine